
M K Proteins Limited
The current stock price of M K Proteins Limited is ₹6.14, with a target price range between ₹5.83 and ₹6.45. The stock has experienced a price change of ₹-0.43 (-6.54%), reflecting recent market volatility.
Today's opening price was ₹6.60, while the previous close stood at ₹6.57.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
M K Proteins Limited Price Chart
M K Proteins Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 6.6
- Previous Close Price: 6.57
- Change: 0.03%
- Total Traded Volume: 4,963
- Total Buy Quantity: 57,066
- Total Sell Quantity: 19,960
Price | Buy Qty | Sell Qty |
---|---|---|
6.45 | 401.00 | 0.00 |
6.47 | 1.00 | 0.00 |
6.48 | 2,001.00 | 0.00 |
6.50 | 360.00 | 0.00 |
6.57 | 539.00 | 0.00 |
6.60 | 0.00 | 2,988.00 |
6.65 | 0.00 | 1,000.00 |
6.70 | 0.00 | 100.00 |
6.75 | 0.00 | 11.00 |
6.80 | 0.00 | 1,450.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns of M K Proteins Limited
Key Trade Statistics of M K Proteins Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 11.96 |
Traded Value (₹ Cr.) | 0.73 |
Total Market Cap (₹ Cr.) | 230.48 |
Free Float Market Cap (₹ Cr.) | 58.02 |
Impact cost | 2.67 |
Quantity Traded | 1,195,962.00 |
Deliverable Quantity | 660,811.00 |
% of Quantity to Traded | 55.25 |
Security VaR | 19.27 |
Index VaR | N/A |
VaR Margin | 21.5 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 25 |
Face Value | 1 |
Key Price Statistics of M K Proteins Limited
The 52-week high for M K Proteins Limited was ₹15.00, recorded on 21-May-2024. On the other hand, the 52-week low stands at ₹5.91, with the lowest value recorded on 13-Mar-2025.
The upper band for trading is ₹7.22, and the lower band is ₹5.91. The price band is 10%.
The stock's daily volatility stands at 2.94, while the annualized volatility is 56.17. The tick size for trading is ₹0.01.
Price Information | Details |
---|---|
52 Week High (21-May-2024) | 15.00 |
52 Week Low (13-Mar-2025) | 5.91 |
Upper Band | 7.22 |
Lower Band | 5.91 |
Price Band (%) | 10 |
Daily Volatility | 2.94 |
Annualised Volatility | 56.17 |
Tick Size | 0.01 |
Key Securities Statistics of M K Proteins Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 13-Jun-2023 |
Adjusted P/E | 21.57 |
Symbol P/E | 21.57 |
Index | NA |
Macro-Economic Sector | Fast Moving Consumer Goods |
Sector | Fast Moving Consumer Goods |
Industry | Agricultural Food & other Products |
Basic Industry | Edible Oil |
Security Status of M K Proteins Limited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of M K Proteins Limited
Subject | Date |
---|---|
Copy of Newspaper Publication | 17-Feb-2025 |
Integrated Filing- Financial | 14-Feb-2025 |
Outcome of Board Meeting | 13-Feb-2025 |
Financial Result Updates | 13-Feb-2025 |
Board Meeting Intimation | 07-Feb-2025 |
Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 11-Jan-2025 |
Trading Window-XBRL | 31-Dec-2024 |
Trading Window | 31-Dec-2024 |
Corporate Actions of M K Proteins Limited
Face Value | Purpose | Ex-Date |
---|---|---|
1 | Annual General Meeting | 23-Sep-2024 |
1 | Bonus 2:1 | 15-Mar-2024 |
1 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share | 10-Nov-2023 |
1 | Annual General Meeting | 22-Sep-2023 |
Board Meetings of M K Proteins Limited
Financial Results of M K Proteins Limited
Company Directory of M K Proteins Limited
Web Address | Office | Address | City |
---|---|---|---|
www.mkproteins.in | Registered Office | Naraingarh Road Vill. Garnala Ambala City |
N/A |
www.mkproteins.in | Registered Office | Naraingarh Road Vill. Garnala Ambala City |
N/A |
www.mkproteins.in | Transfer Agent | Bigshare Services Private Limited E2 Ansa Industrial Estate, Sakivihar Road, Sakinaka Andheri East |
MUMBAI |
www.mkproteins.in | Transfer Agent | Bigshare Services Private Limited E2 Ansa Industrial Estate, Sakivihar Road, Sakinaka Andheri East |
MUMBAI |
Insider Trading of M K Proteins Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | PARMOD KUMAR HUF | 0 | Sell |
7(2) | - | - | - |
7(2) | PARMOD KUMAR HUF | 0 | Sell |
7(2) | PARMOD KUMAR | 0 | Buy |
7(2) | MANIK GARG | 0 | Buy |
7(2) | NEELESH GARG | 0 | Buy |
7(2) | PARVIND KUMAR | 29922048 | Sell |
7(2) | VINOD KUMAR | 29922048 | Sell |
7(2) | RAJ KUMAR GARG | 29922048 | Sell |
7(2) | PARMOD KUMAR | 29893248 | Sell |
7(2) | SHREE GANESH FATS PRIVATE LIMITED | 119899008 | Buy |
Annual Reports of M K Proteins Limited
Investor Complaints of M K Proteins Limited
Event Calendar of M K Proteins Limited
Purpose | Details |
---|---|
Results | For Adoption of Un-Audited Financial Statements for the Year Half yearly ended September 30, 2017. |
Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
Financial Results | inter alia, to consider and approve Un-audited Financial Results for the quarter ended on September 30, 2018. |
Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2019 and other business matters |
Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
Financial results | M K Proteins Limited has informed the Exchange about Board Meeting to be held on 30-May-2022 to consider financial statements for the period ended March 2022 |
Bonus/Other business matters | M K Proteins Limited in continuation of prior intimation of Board Meeting to be held on 14-Nov-2022 hereby further informs the Exchange to consider Bonus and Other Business matters in the forthcoming meeting. The Company earlier intimated the exchange on 05th November, 2022 about the Board Meeting it proposes to hold on 14th November, 2022 to consider Un-Audited Financial Results for the half-year ended. This Notice is an addendum to the original notice and that the Board proposes to consider these business in addition to the business earlier proposed. |
Financial results | M K Proteins Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 |
Bonus | Board Meeting Intimation for Allotment Of Bonus Equity Shares Scheduled To Be Held On 7Th February, 2023 |
Financial Results | Intimation of Meeting of the Board of Directors to consider, approve & take on record Audited Financial Results for half yearly and year ended on March 31, 2023 |
Financial Results/Other business matters | To consider and approve the un-audited financial results for the quarter ended Jun 30, 2023 and other business matters |
Other business matters | Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 5th September, 2023 to inter-alia, to transact the following businesses:1. To fix the date, time and venue for convening the 11th Annual General Meeting ( AGM ) of the shareholders of the Company;2. To consider and approve the draft of Notice of 11th Annual General Meeting ( AGM ) and Director s Report along with applicable annexures thereto;3. To fix and decide the Book Closure date and Cut-off date for the purpose of 11th Annual General Meeting of the Company;4. Any other matter with the permission of chair.You are requested to kindly take the same on your records. |
Stock Split | To consider stock split of equity shares |
Financial Results/Other business matters | The Company has informed the Exchange that a Board meeting to be held on November 10, 2023 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2023, To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the quarter and half year ended September 30, 2023 and other business matters |
Bonus/Other business matters | To consider issuance of bonus shares and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Financial Results | To consider and approve the financial results for the year ended March 31, 2024 and any ther business. |
Financial Results | We hereby intimate that the meeting of the Board of Directors of the Company will be held on Tuesday, 13th August 2024 to inter-alia, consider and approve the following items:1. The Un-Audited Financial Results of the Company for the quarter ended 30th June, 2024;2. Any other business with the permission of chair. |
Other business matters | Intimation of Board Meeting to be held to fix the date, time and venue for convening the 12th Annual General Meeting ( AGM ) of the shareholders of the Company and to approve the Notice and Directors' Report and to fix Book Closure Date |
Financial Results | To consider and approve the following businesses:1. The Un-audited Financial Results of the Company for the quarter and half year ended 30th September, 2024;2. Any other items with the permission of the chairman |
Financial Results/Other business matters | To consider and approve the financial results for the quarter and nine months ended December 31, 2024 and other business matters |
Share Transfers of M K Proteins Limited
Voting Results of M K Proteins Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
30-SEP-2024 | AGM | To receive, consider and adopt the Financial Statements including Audited BalancenSheet of the Company as at 31st March, 2024, the Statement of Profit and Loss and Cash FlownStatement for the year ended on that date together with reports of the Board of Directors andnthe Auditors thereon |
30-SEP-2024 | AGM | Approval for Material Transactions with Related Parties |
30-SEP-2024 | AGM | To ratify the remuneration of the Cost Auditors for the financial year 2024-25 |
30-SEP-2024 | AGM | To approve the re-appointment of M/s K R A & CO., as the Statutory Auditors of the company to hold office from the conclusion of this meeting until the conclusion of the Annual General Meeting of the Company to be held in the year 2029 |
30-SEP-2024 | AGM | To re-appoint Sh. Raj Kumar, Director who retires by rotation at this meeting and,nbeing eligible, offered himself for re-appointment. |
03-MAR-2024 | Postal Ballot | To Increase in Authorized Share Capital of the Company and consequent alteration in Capital Clause of the Memorandum of Association of the Company |
03-MAR-2024 | Postal Ballot | Issue Of Bonus Equity Shares to the existing Shareholders of the Company |
25-OCT-2023 | Postal Ballot | SUB-DIVISION OF FACE VALUE OF EQUITY SHARES OF THE COMPANY FROM RS. 10/- (RUPEES TEN ONLY) EACH TO RE. 1/- (RUPEE ONE) EACH |
25-OCT-2023 | Postal Ballot | ALTERATION OF CAPITAL CLAUSE OF MEMORANDUM OF ASSOCIATION OF THE COMPANY CONSEQUENT TO SUB-DIVISION OF FACE VALUE OF THE SHARES OF THE COMPANY |
29-SEP-2023 | AGM | To receive, consider and adopt the Financial Statements including Audited Balance Sheet of the Company as at 31st March, 2023, the Statement of Profit and Loss and Cash Flow Statement for the year ended on that date together with reports of the Board of Directors and the Auditors thereon: |
29-SEP-2023 | AGM | Approval for Material Transactions with Related Parties: |
29-SEP-2023 | AGM | To reappoint Independent Director Mrs. Swati Gupta: |
29-SEP-2023 | AGM | To ratify the remuneration of the Cost Auditors for the financial year 2022-23: |
29-SEP-2023 | AGM | To approve appointment of Auditors for the year ending from 31st March 2024 and fix their remuneration. M/s K R A & CO., KATHUA -185101, proposed to be appointed as Statutory Auditors for Financial Year ending 31st March 2024 being eligible to act as Statutory Auditors from the conclusion of this meeting till the conclusion of next Annual General Meeting to be held for Financial Year ending 31st March, 2024. |
29-SEP-2023 | AGM | To re-appoint Sh. Parvind Kumar, Director who retires by rotation at this meeting and, being eligible, offered himself for re-appointment. |
04-AUG-2023 | EGM | Approval of Appointment of Sh. Tej Mohan Singh (DIN: 10130417) as a Non-Executive Independent Director of the Company |
04-AUG-2023 | EGM | Approval of Appointment of Ms. Shipra Jain (DIN: 10130874) as a Non-Executive Independent Director of the Company |
22-DEC-2022 | Postal Ballot | To Increase in Authorized Share Capital of the Company and consequent Alteration in Capital Clause of the Memorandum of Association of the Company |
22-DEC-2022 | Postal Ballot | To migration of Equity Shares of the Company from NSE SME Platform to Main Board of National Stock Exchange of India Limited (NSE) |
22-DEC-2022 | Postal Ballot | To Issue of Bonus Shares |
FAQs on M K Proteins Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.